Selskabets formål er at drive handel og fabrikation, særligt inden for distribution af medicinsk udstyr og anden i forbindelse hermed stående virksomhed, samt distribution af humane lægemidler, medicinsk udstyr og dermed beslægtede produkter samt andre aktiviteter godkendt af bestyrelsen.
| Year | Revenue | Profit/Loss | Total Assets | Equity | Employees | Report |
|---|---|---|---|---|---|---|
| 2025 | 645.2 mio. | 19.7 mio. | 334.9 mio. | 141.9 mio. | 202 | |
CVR: 18491370
Secondary names: Covidien Danmark A/S, Tycho Healthcare Denmark A/S
Compared to 288 companies in Engroshandel med læge- og hospitalsartikler
Comparison is based on industry median values
Jeppe Højholt-Nielsen joined the board
Panu Samuel Lauha left the board
Companies in the same industry and area
CVR 41722460
CVR 39371049
CVR 39503778
CVR 40873309
CVR 31774284
The financial health of MEDTRONIC DANMARK A/S appears robust, with a consistent upward trajectory in both revenue and profit over the past five years. Revenue increased from 552.9 million DKK in 2021 to 645.2 million DKK in 2025, while profit rose from 13.8 million DKK to 19.7 million DKK during the same period. This growth reflects a solid performance in the medical and hospital supplies sector, supported by a healthy equity position that reached 141.9 million DKK in 2025. However, the company should monitor its profit margins and any potential debt levels, as these factors could impact future growth. Overall, MEDTRONIC DANMARK A/S is well-positioned within its industry, demonstrating resilience and a positive financial trajectory.
AI-generated summary
companydata.dk